Biofrontera Inc. Interest Income, Related Party
Biofrontera Inc. (BFRI) reported Interest Income, Related Party of $165.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-13.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeRelatedParty · last filed 2023-03-13
- Biofrontera Inc. interest income, related party for the quarter ending 2022-12-31 was $55.00K.
- Biofrontera Inc. interest income, related party for the quarter ending 2022-09-30 was $1.00K.
- Biofrontera Inc. interest income, related party for the quarter ending 2022-06-30 was $53.00K.
- Biofrontera Inc. interest income, related party for the quarter ending 2022-03-31 was $60.00K, a 1100.00% increase year-over-year.
- Biofrontera Inc. interest income, related party for fiscal 2022 was $165.00K.
| Period end | Interest Income, Related Party 3 month | Interest Income, Related Party 6 month | Interest Income, Related Party 9 month | Interest Income, Related Party 12 month |
|---|---|---|---|---|
| 2022-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $56.00K derived: sum of 2 quarters · filed 2023-03-13 | $109.00K derived: sum of 3 quarters · filed 2023-03-13 | $165.00K 10-K · filed 2023-03-13 |
| 2022-09-30 | $1.00K 10-Q · filed 2022-11-14 | $54.00K derived: sum of 2 quarters · filed 2022-11-14 | $110.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $53.00K 10-Q · filed 2022-08-12 | $110.00K 10-Q · filed 2022-08-12 | ||
| 2022-03-31 | $60.00K 10-Q · filed 2022-05-13 | |||
| 2021-03-31 | $5.00K 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |